Outcome
    Moderate Evidence

    Probiotics for Bacterial Infection Prevention

    Well-supported for preventing gut infections during antibiotic courses; less clear for other bacterial infections.

    Overview

    Probiotics for infection prevention is a claim that deserves precision. The trial data support a modest reduction in the number of people who get certain common infections, chiefly upper respiratory and recurrent urinary tract infections, when a well-characterised strain is taken daily for months. What the data do not support is broad protection against bacterial infection in general. Benefit is strain-specific and site-specific, so matching the product to the studied strain matters more than the size of the number on the label.

    What the evidence supports

    Fewer infection episodes and less antibiotic use in some populations, with low to moderate certainty.

    How It Works

    Selected Lactobacillus and Bifidobacterium strains compete with pathogens for adhesion sites and nutrients, produce organic acids and bacteriocins, tighten epithelial junctions, and prompt secretory IgA responses at the mucosal surface.
    These effects are strain-dependent and largely transient. Most supplemented organisms do not colonise permanently, which is why continuous daily dosing is what the prevention trials tested.

    Dosing & Protocol

    Match the strain first, then the dose. Counts below reflect what the prevention trials used, and higher counts have not reliably produced better outcomes.

    Prevention takes months

    These trials dosed continuously for six months or more. A two-week course is not a fair test.

    Evidence

    Two linked reviews sit behind this verdict: a Cochrane review of respiratory infection prevention and a pooled analysis of prophylaxis for recurrent urinary tract infection.

    Probiotics for preventing acute upper respiratory tract infections

    Score: 8/10
    2022
    systematic_review

    Probiotics may modestly reduce upper respiratory infection episodes, but certainty of evidence is low.

    View source

    Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections

    Score: 8/10
    2024
    meta_analysis

    Probiotic prophylaxis did not significantly reduce recurrent urinary tract infections versus placebo.

    View source
    Both reviews find benefit, and both flag the same weaknesses: small trials, varied strains and inconsistent reporting. That combination supports a likely verdict rather than a strong one.

    Safety

    Healthy adults tolerate probiotics well, with transient bloating or wind in the first week. The meaningful caution is immunocompromise: in critically ill, post-transplant or catheterised patients there are case reports of probiotic organisms causing bloodstream infection.

    Not for everyone

    Avoid unsupervised use if you are immunocompromised, seriously ill, or have a central venous catheter.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    —Separate doses by two to three hours
    —Seek medical advice before starting
    —Avoid unless supervised

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.